COLIZZI, Marco
 Distribuzione geografica
Continente #
AS - Asia 2.408
NA - Nord America 1.297
EU - Europa 1.016
SA - Sud America 225
AF - Africa 26
OC - Oceania 9
Totale 4.981
Nazione #
SG - Singapore 1.689
US - Stati Uniti d'America 1.232
IT - Italia 407
HK - Hong Kong 325
CN - Cina 228
BR - Brasile 206
RU - Federazione Russa 197
IE - Irlanda 96
DE - Germania 78
KR - Corea 56
CA - Canada 44
FI - Finlandia 38
IN - India 35
NL - Olanda 35
AT - Austria 33
GB - Regno Unito 31
FR - Francia 21
DK - Danimarca 17
BD - Bangladesh 13
MX - Messico 13
TR - Turchia 13
BE - Belgio 11
TG - Togo 11
AR - Argentina 9
ES - Italia 9
IL - Israele 9
PL - Polonia 8
AU - Australia 6
CZ - Repubblica Ceca 6
VN - Vietnam 6
RS - Serbia 5
UZ - Uzbekistan 5
ET - Etiopia 4
ID - Indonesia 4
JO - Giordania 4
MA - Marocco 4
PA - Panama 4
BG - Bulgaria 3
CL - Cile 3
HU - Ungheria 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
PT - Portogallo 3
RO - Romania 3
UA - Ucraina 3
ZA - Sudafrica 3
CH - Svizzera 2
EC - Ecuador 2
EG - Egitto 2
GY - Guiana 2
IQ - Iraq 2
JP - Giappone 2
PH - Filippine 2
SE - Svezia 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.981
Città #
Singapore 384
Hong Kong 324
Chandler 250
Boardman 139
Beijing 103
Dublin 94
Princeton 84
Ashburn 63
Hefei 56
Seoul 56
Milan 47
Rome 43
Toronto 37
Andover 30
Nuremberg 23
Trieste 23
Ogden 20
São Paulo 20
Vienna 19
Hyderabad 18
Lappeenranta 18
Chicago 16
Copenhagen 16
Düsseldorf 16
Frankfurt am Main 16
Helsinki 15
Los Angeles 15
Ningbo 13
Santa Clara 13
Brussels 11
Lomé 11
Venice 11
Istanbul 10
Udine 10
Verona 10
Portsmouth 9
Naples 8
New York 8
Amsterdam 7
Denver 7
Seattle 7
Belluno 6
Bergamo 6
Curitiba 6
Porcia 6
Pune 6
Treviso 6
Turin 6
Brasília 5
Brooklyn 5
Dallas 5
Lauterbourg 5
Lonato 5
London 5
Rio de Janeiro 5
Shenzhen 5
Tel Aviv 5
The Dalles 5
Ancona 4
Belgrade 4
Belo Horizonte 4
Bologna 4
Boston 4
Brno 4
Broomfield 4
Charlotte 4
Codroipo 4
Dongguan 4
Duque de Caxias 4
Florence 4
Genoa 4
Munich 4
Perugia 4
Santa Maria 4
Sydney 4
Tashkent 4
Treia 4
Vignate 4
Warsaw 4
Alcantarilla 3
Atlanta 3
Auckland 3
Betim 3
Buffalo 3
Cavasso Nuovo 3
Conceição do Mato Dentro 3
Conselheiro Lafaiete 3
Dhaka 3
Durham 3
Edinburgh 3
Groningen 3
Iași 3
Jerash 3
Mexico City 3
Modesto 3
Monterrey 3
Padova 3
Pelotas 3
Piacenza 3
Piracicaba 3
Totale 2.319
Nome #
Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years 227
Therapeutic Effect of Palmitoylethanolamide in Cognitive Decline: A Systematic Review and Preliminary Meta-Analysis of Preclinical and Clinical Evidence 200
Prenatal insomnia disorder may predict concurrent and postpartum psychopathology: A longitudinal study 163
Impact of COVID-19 on behavior in autism spectrum disorder 157
Occupational Stress Among Italian Postgraduate Medical Trainees: A Pilot Study for the Validation of the SCOPE Questionnaire 155
Challenges in addressing youth mental health 155
In Web We Trust: The Promised Cannabidiol Effects on Obesity as a Matter of Language and Marketing on Webpages 154
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 72
Feigning Capgras Syndrome and Developmental Prosopagnosia: a rare case of Pediatric Factitious Disorder 66
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 58
The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends 57
21.5 Repercussions of the First and Second COVID-19 Waves in the Italian Pediatric Population: An Inpatient Psychiatric Emergency Study 51
Cannabis use and the development of tolerance: a systematic review of human evidence 49
Cannabis and cognition: Connecting the dots towards the understanding of the relationship 49
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains 48
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids 48
Mentalization in young patients undergoing opioid agonist treatment: Implications for clinical management 47
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 47
Editorial: Case reports in autism 46
4.4 IS ALTERED SENSORIMOTOR INTEGRATION A CORE FEATURE OF TOURETTE'S DISORDER? A CASE-CONTROL STUDY 46
51.18 THE COVID-19 OUTBREAK IMPACT ON WELL-BEING AMONG PEOPLE WITH AUTISM SPECTRUM DISORDER IN ITALY: AN N = 527 WEB-BASED SURVEY 46
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis 45
Confirmation of increased and more severe adolescent mental health-related in-patient admissions in the COVID-19 pandemic aftermath: A 2-year follow-up study 44
Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study 44
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes 43
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 43
Adolescent lifestyle behaviors, coping strategies and subjective wellbeing during the covid-19 pandemic: An online student survey 43
Effectiveness of equine-assisted activities and therapies for improving adaptive behavior and motor function in autism spectrum disorder 42
The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System 42
Prevention in Mental Health: From Risk Management to Early Intervention 41
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis 41
Cannabis and psychosis: What do we know and what should we do? 41
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults 40
Attachment styles in transsexual patients and clinical and nonclinical control groups: A Response 40
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence 40
Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: A 2year follow-up study 40
Further evidence on the interplay between benzodiazepine and Z-drug abuse and emotion dysregulation 40
Additional evidence for neuropsychiatric manifestations in mosaic trisomy 20: A case report and brief review 39
Cannabis: Neuropsychiatry and its effects on brain and behavior 39
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence 39
CaReL Guideline: A Consensus-Based Guideline on Case Reports and Literature Review (CaReL) 38
Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two cases 38
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence 38
Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria 38
Where Do Neurodevelopmental Disorders Go? Casting the Eye Away from Childhood towards Adulthood 37
Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration 37
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 37
Poster #35 STUDYING EPISODIC MEMORY CEREBRAL NETWORK: A NOVEL EVENT-RELATED TASK FOR FMRI 36
Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: A systematic review of human and animal evidence 36
COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection 35
Disturbi d’ansia 35
Hyperprolactinaemia in first episode psychosis - A longitudinal assessment 35
Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study 34
Neurobiological underpinnings of the effects of cannabinoids 34
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 34
Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review 33
Investigating gait, movement, and coordination in children with neurodevelopmental disorders: Is there a role for motor abnormalities in atypical neurodevelopment? 33
Differential gene expression analysis in blood of first episode psychosis patients 33
Risk of psychosis in autism spectrum disorder individuals exposed to psychosocial stressors: A 9-year chart review study 32
Lessons Learnt From Running a Transition-Age Youth Mental Health Outpatient Clinic in Italy: The PRecocity of Intervention in Adolescent Medicine (PRIMA) Experience 32
Pediatric emergency department mental health assessments in the 2 years following the COVID-19 outbreak reveal higher vulnerability for eating disorder and suicide risk 32
COGNITIVE DEFICITS AS INTERMEDIATE PHENOTYPE IN SCHIZOPHRENIA 32
Postural control in childhood: Investigating the neurodevelopmental gradient hypothesis 32
Lo stigma nella salute mentale 32
Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: Results from a longitudinal study 31
Cannabis and Psychosis 30
Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence 30
O3.4. DOES CANNABIS INDUCE PSYCHOSIS BY ALTERING GLUTAMATE SIGNALING IN THE STRIATUM? 30
Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example 29
Expert consensus riguardante cannabis, cannabinoidi e prodotti derivati 29
Clinical heterogeneity of feeding and eating disorders: using personality psychopathology to differentiate “simplex” and “complex” phenotypes 29
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis 29
The effect of cross-sex hormonal treatment on gender dysphoria individuals’ mental health: A systematic review 29
Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021 29
Un adolescente con insolita sintomatologia ai tempi del COVID-19 28
Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populations 28
Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report 28
The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis 28
Editorial: Methods and applications in addiction psychiatry research: 2021 27
Poster #103 INTERACTION BETWEEN COMT GENOTYPE, CANNABIS USE, AND BFQ MEASURES OF SOCIABILITY 27
Prevalence and risk factors for depression in factitious disorder: a systematic review 26
Psychological factors associated with vaccination hesitancy: an observational study of patients hospitalized for COVID-19 in a later phase of the pandemic in Italy 26
Association between stressful life events and psychosis relapse: a 2-year prospective study in first-episode psychosis 26
Psico-oncologia e psichiatria in medicina palliativa 26
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis 26
Tic-Related Obsessive-Compulsive and Eating Disorders in Dandy-Walker Variant: A Case Report and Systematic Reappraisal of Psychiatric Profiles 26
Changes in Revolving-Door Mental Health Hospitalizations during the COVID-19 Pandemic: A 5-Year Chart Review Study 26
Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses 25
Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in Adolescents 25
Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY 25
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A) 25
Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol 25
Evidence for endocannabinoid-like compound supplementation for human health 24
Introduction 24
Vortioxetine Add-On to Methylphenidate for the Treatment of Symptoms of Sickness Behavior in Attention-Deficit Hyperactivity Disorder: Report of Two Cases 24
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 24
Is there sufficient evidence that cannabis use is a risk factor for psychosis? 24
Stigma as the main obstacle in health care and human rights among people with mental disorders. A rights-based ethics approach 24
Epigenetic Regulation and Genetic Variation of AKT1 Predict Prefrontal Physiology 24
Dissociative symptoms in individuals with gender dysphoria: Is the elevated prevalence real? 24
Totale 4.520
Categoria #
all - tutte 34.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022463 0 0 0 0 0 0 92 175 0 0 41 155
2022/2023745 87 13 27 88 63 177 34 56 93 35 43 29
2023/2024458 47 40 14 12 29 20 37 91 42 44 41 41
2024/20253.761 106 151 146 99 85 184 214 190 347 258 900 1.081
Totale 5.427